Pelthos Therapeutics, Inc. (PTHS)
24.00
-1.03
(-4.12%)
USD |
NYAM |
Dec 11, 16:00
24.00
0.00 (0.00%)
After-Hours: 20:00
Pelthos Therapeutics Total Liabilities (Quarterly): 68.18M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 526.60M |
| Agenus, Inc. | 514.76M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Travere Therapeutics, Inc. | 465.02M |
| Genprex, Inc. | 2.795M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.43M |
| Shareholders Equity (Quarterly) | 58.25M |
| Debt to Equity Ratio | 0.0597 |
| Current Ratio | 1.980 |
| Net Debt Paydown Yield | -3.77% |